Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: Macrophage scavenger receptor regulation

Song Jin, A. Scott Mathis, Joseph Rosenblatt, Tamara Minko, S. Gary Friedman, Kevin Gioia, David S. Serur, Gregory T. Knipp

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Clinical monitoring of organ-transplant recipients suggests that administration of cyclosporine (CsA) may increase the risk of atherosclerosis when compared with the general population. The purpose of this work is to demonstrate the utility of the in vitro Tamm-Horsfall protein (THP)-1 human monocyte cell culture model for determining drug-related atherosclerotic potential in macrophages. The effect of CsA on the mRNA expression of macrophage scavenger receptor genes including CD36, CD68, scavenger receptor (SR)-A, SR-BII, and lectin-like oxidized low-density lipoprotein receptor (LOX-1); the nuclear hormone receptors, including peroxisome-proliferator activated receptor (PPAR)γ and liver-X-receptor (LXR)α; and the cholesterol efflux pump ABCA1 were investigated as markers of atherosclerotic progression. The THP-1 cells were cultured and differentiated into macrophages. The macrophages were then treated with CsA to assess gene expression. Time- (1, 2, 4, 8, and 24 hours) and dose- (concentrations [mg/L] corresponding to the trough [0.5], peak [1.25] and 4x peak [5]) dependency of CsA was assessed. The treated macrophage mRNA gene expression of CD36, CD68, and PPARγ were up-regulated in the presence of CsA. Interestingly, SR-A, SR-BII, LOX-1, and LXRα expression appeared to be slightly down-regulated, and ABCA1 was relatively unchanged. Immunoblotting studies demonstrated that the protein expression of CD36 was unchanged or increased, PPARγ was unchanged, and ABCA1 was unchanged or decreased at 4 and 8 hours. The results document CsA-induced mRNA and protein changes in receptors relevant to lipid-laden foam cell formation and demonstrate the utility of THP-1 macrophages for screening of atherosclerotic risk potential.

Original languageEnglish (US)
Pages (from-to)497-504
Number of pages8
JournalTransplantation
Volume77
Issue number4
DOIs
StatePublished - Feb 27 2004

Fingerprint

Scavenger Receptors
Cyclosporine
Macrophages
Peroxisome Proliferator-Activated Receptors
Uromodulin
Messenger RNA
Class E Scavenger Receptors
CD36 Antigens
Gene Expression
Foam Cells
Cytoplasmic and Nuclear Receptors
Immunoblotting
Monocytes
Cultured Cells
Atherosclerosis
Cell Culture Techniques
Cholesterol
Transplant Recipients
Transplants
Lipids

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

Jin, Song ; Mathis, A. Scott ; Rosenblatt, Joseph ; Minko, Tamara ; Friedman, S. Gary ; Gioia, Kevin ; Serur, David S. ; Knipp, Gregory T. / Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients : Macrophage scavenger receptor regulation. In: Transplantation. 2004 ; Vol. 77, No. 4. pp. 497-504.
@article{2f67a36643ca49008fdc2e8feee825fd,
title = "Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: Macrophage scavenger receptor regulation",
abstract = "Clinical monitoring of organ-transplant recipients suggests that administration of cyclosporine (CsA) may increase the risk of atherosclerosis when compared with the general population. The purpose of this work is to demonstrate the utility of the in vitro Tamm-Horsfall protein (THP)-1 human monocyte cell culture model for determining drug-related atherosclerotic potential in macrophages. The effect of CsA on the mRNA expression of macrophage scavenger receptor genes including CD36, CD68, scavenger receptor (SR)-A, SR-BII, and lectin-like oxidized low-density lipoprotein receptor (LOX-1); the nuclear hormone receptors, including peroxisome-proliferator activated receptor (PPAR)γ and liver-X-receptor (LXR)α; and the cholesterol efflux pump ABCA1 were investigated as markers of atherosclerotic progression. The THP-1 cells were cultured and differentiated into macrophages. The macrophages were then treated with CsA to assess gene expression. Time- (1, 2, 4, 8, and 24 hours) and dose- (concentrations [mg/L] corresponding to the trough [0.5], peak [1.25] and 4x peak [5]) dependency of CsA was assessed. The treated macrophage mRNA gene expression of CD36, CD68, and PPARγ were up-regulated in the presence of CsA. Interestingly, SR-A, SR-BII, LOX-1, and LXRα expression appeared to be slightly down-regulated, and ABCA1 was relatively unchanged. Immunoblotting studies demonstrated that the protein expression of CD36 was unchanged or increased, PPARγ was unchanged, and ABCA1 was unchanged or decreased at 4 and 8 hours. The results document CsA-induced mRNA and protein changes in receptors relevant to lipid-laden foam cell formation and demonstrate the utility of THP-1 macrophages for screening of atherosclerotic risk potential.",
author = "Song Jin and Mathis, {A. Scott} and Joseph Rosenblatt and Tamara Minko and Friedman, {S. Gary} and Kevin Gioia and Serur, {David S.} and Knipp, {Gregory T.}",
year = "2004",
month = "2",
day = "27",
doi = "10.1097/01.TP.0000109690.44426.20",
language = "English (US)",
volume = "77",
pages = "497--504",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients : Macrophage scavenger receptor regulation. / Jin, Song; Mathis, A. Scott; Rosenblatt, Joseph; Minko, Tamara; Friedman, S. Gary; Gioia, Kevin; Serur, David S.; Knipp, Gregory T.

In: Transplantation, Vol. 77, No. 4, 27.02.2004, p. 497-504.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients

T2 - Macrophage scavenger receptor regulation

AU - Jin, Song

AU - Mathis, A. Scott

AU - Rosenblatt, Joseph

AU - Minko, Tamara

AU - Friedman, S. Gary

AU - Gioia, Kevin

AU - Serur, David S.

AU - Knipp, Gregory T.

PY - 2004/2/27

Y1 - 2004/2/27

N2 - Clinical monitoring of organ-transplant recipients suggests that administration of cyclosporine (CsA) may increase the risk of atherosclerosis when compared with the general population. The purpose of this work is to demonstrate the utility of the in vitro Tamm-Horsfall protein (THP)-1 human monocyte cell culture model for determining drug-related atherosclerotic potential in macrophages. The effect of CsA on the mRNA expression of macrophage scavenger receptor genes including CD36, CD68, scavenger receptor (SR)-A, SR-BII, and lectin-like oxidized low-density lipoprotein receptor (LOX-1); the nuclear hormone receptors, including peroxisome-proliferator activated receptor (PPAR)γ and liver-X-receptor (LXR)α; and the cholesterol efflux pump ABCA1 were investigated as markers of atherosclerotic progression. The THP-1 cells were cultured and differentiated into macrophages. The macrophages were then treated with CsA to assess gene expression. Time- (1, 2, 4, 8, and 24 hours) and dose- (concentrations [mg/L] corresponding to the trough [0.5], peak [1.25] and 4x peak [5]) dependency of CsA was assessed. The treated macrophage mRNA gene expression of CD36, CD68, and PPARγ were up-regulated in the presence of CsA. Interestingly, SR-A, SR-BII, LOX-1, and LXRα expression appeared to be slightly down-regulated, and ABCA1 was relatively unchanged. Immunoblotting studies demonstrated that the protein expression of CD36 was unchanged or increased, PPARγ was unchanged, and ABCA1 was unchanged or decreased at 4 and 8 hours. The results document CsA-induced mRNA and protein changes in receptors relevant to lipid-laden foam cell formation and demonstrate the utility of THP-1 macrophages for screening of atherosclerotic risk potential.

AB - Clinical monitoring of organ-transplant recipients suggests that administration of cyclosporine (CsA) may increase the risk of atherosclerosis when compared with the general population. The purpose of this work is to demonstrate the utility of the in vitro Tamm-Horsfall protein (THP)-1 human monocyte cell culture model for determining drug-related atherosclerotic potential in macrophages. The effect of CsA on the mRNA expression of macrophage scavenger receptor genes including CD36, CD68, scavenger receptor (SR)-A, SR-BII, and lectin-like oxidized low-density lipoprotein receptor (LOX-1); the nuclear hormone receptors, including peroxisome-proliferator activated receptor (PPAR)γ and liver-X-receptor (LXR)α; and the cholesterol efflux pump ABCA1 were investigated as markers of atherosclerotic progression. The THP-1 cells were cultured and differentiated into macrophages. The macrophages were then treated with CsA to assess gene expression. Time- (1, 2, 4, 8, and 24 hours) and dose- (concentrations [mg/L] corresponding to the trough [0.5], peak [1.25] and 4x peak [5]) dependency of CsA was assessed. The treated macrophage mRNA gene expression of CD36, CD68, and PPARγ were up-regulated in the presence of CsA. Interestingly, SR-A, SR-BII, LOX-1, and LXRα expression appeared to be slightly down-regulated, and ABCA1 was relatively unchanged. Immunoblotting studies demonstrated that the protein expression of CD36 was unchanged or increased, PPARγ was unchanged, and ABCA1 was unchanged or decreased at 4 and 8 hours. The results document CsA-induced mRNA and protein changes in receptors relevant to lipid-laden foam cell formation and demonstrate the utility of THP-1 macrophages for screening of atherosclerotic risk potential.

UR - http://www.scopus.com/inward/record.url?scp=1442286883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442286883&partnerID=8YFLogxK

U2 - 10.1097/01.TP.0000109690.44426.20

DO - 10.1097/01.TP.0000109690.44426.20

M3 - Article

C2 - 15084924

AN - SCOPUS:1442286883

VL - 77

SP - 497

EP - 504

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 4

ER -